1. Stocks
    2. /
  2. Etfs S&p Biotech ETF (ASX: CURE)
    3. /

Etfs S&p Biotech ETF (ASX: CURE) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Etfs S&p Biotech ETF Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Etfs S&p Biotech ETF (ASX: CURE)
Latest News

ETF written in yellow with a yellow underline and the full word spelt out in white underneath.
ETFs

2 top ETFs for ASX investors to buy in October

| James Mickleboro

These ETFs could be top options for investors in October...

Read more »

A young woman sits with her hand to her chin staring off to the side thinking about her investments.
ETFs

2 exciting ETFs named as buys by experts

| James Mickleboro

Here are two ETFs that could be buys...

Read more »

CURE ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Young Kim Non-Executive Director Jun 2022
No Profile Reported in Last Annual Report.
Mr Namki Kim Non-Executive Director Jul 2024
No Profile Reported in Last Annual Report.
Mr Alexandre Zaika Non-Executive Director Dec 2024
No Profile Reported in Last Annual Report.
Mr Krzysztof Wolak Non-Executive Director Feb 2025
No Profile Reported in Last Annual Report.

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
No top 20 shareholder's information disclosed 0 0.00%

Profile

since

Note